Liquidia Corporation Provides Update on New Drug Application for YUTREPIA™ (treprostinil) inhalation powder
MORRISVILLE, N.C., Jan. 25, 2024 -- Liquidia Corporation announced today that the U.S. Food and Drug Administration provided an update on its review of the New Drug Application for YUTREPIA™ ...